Bayesian Capital Management’s CDK Global, Inc. CDK Stock Holding History

Bayesian Capital Management’s Portfolio CDK Stock Details CDK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,334	Closed	-$275K	–	781
2018 Q1	$275K	Buy	+4,334	New	+$303K	0.07%	418
2017 Q2	–	Sell	-7,530	Closed	-$490K	–	641
2017 Q1	$490K	Sell	7,530 -100	-1%	-$6.4K	0.23%	167
2016 Q4	$455K	Buy	+7,630	New	+$436K	0.11%	328

Other funds holding CDK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bayesian Capital Management's CDK Position: Q2 2018 in Review

Bayesian Capital Management sold out of CDK Global, Inc. (CDK) in Q2 2018, closing a stake of 4,334 shares — an estimated $275K sold.

Bayesian Capital Management first reported a position in CDK in Q4 2016 and held it in 3 quarters. The position peaked at $490K in Q1 2017. 602 funds tracked by Wall St. Rank hold CDK as of Q2 2018.

Bayesian Capital Management reported no remaining CDK Global, Inc. position as of Q2 2018 after selling out during the quarter.
Bayesian Capital Management sold 4,334 CDK Global, Inc. shares in Q2 2018, an estimated $275K.
Bayesian Capital Management first reported a position in CDK Global, Inc. in Q4 2016 and held it in 3 quarters.
Bayesian Capital Management's CDK Global, Inc. position peaked at $490K in Q1 2017.
602 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q2 2018.

Based on Bayesian Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.